Find a Study Now
Welcome to the future of
clinical research recruitment

Receive The Newest Study Notifications

Select Page

Latest News on Clinical Trials

BeiGene Announces that the Phase 3 Clinical Trial of its Anti-PD-1 Antibody Tislelizumab in Patients with First-Line Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis

BEIJING, China, and CAMBRIDGE, Mass., Jan. 21, 2020 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE, HKEX: 06160)), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the...

read more

Kala completes enrollment in STRIDE 3 trial

Kala Pharmaceuticals has completed enrollment in the STRIDE 3 trial for KPI-121 0.25%, a treatment for temporary dry eye relief, according to a press release. The enrollment follows a previous new drug application rejection from the FDA, which said that efficacy data...

read more

IntraBio Completes NPC Clinical Trial Enrollment

OXFORD, UK / ACCESSWIRE / January 17, 2020 / IntraBio Inc, a late-stage biopharmaceutical company, is pleased to share that it has completed enrollment for its IB1001-201 Clinical Trial. IB1001-201 investigates N-Acetyl-L-Leucine (IB1001) for both the symptomatic, and...

read more